HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Fine Needle Biopsy

A fine needle biopsy (FNB) is a medical procedure used to obtain tissue samples from a suspicious or abnormal mass or lump in the body. This minimally invasive technique involves the use of a thin, hollow needle to extract a small tissue specimen for further examination. Fine needle biopsies are commonly performed to diagnose and analyze various medical conditions, including tumors, cysts, and infections. During the procedure, the patient may be positioned lying down or seated, depending on the location of the targeted mass. The area is typically cleaned and numbed with a local anesthetic to minimize discomfort. The healthcare professional then inserts the fine needle into the targeted area, guided by imaging techniques such as ultrasound or computed tomography (CT) scan. Once the needle is in place, a small sample of tissue is aspirated into a syringe or obtained using a vacuum technique. The collected tissue is then sent to a laboratory for pathological analysis. Pathologists examine the specimen under a microscope to identify any abnormal cellular changes or characteristics. Fine needle biopsy offers several advantages, including its less invasive nature, minimal scarring, and shorter recovery times compared to traditional surgical biopsies. Additionally, it is a valuable diagnostic tool for investigating the nature of a mass or lesion without the need for more extensive procedures. Despite its benefits, fine needle biopsy may not always provide a definitive diagnosis, and further testing or additional biopsies may be required for a comprehensive evaluation. Nevertheless, this procedure remains a crucial and widely utilized method for obtaining diagnostic information in a variety of medical scenarios.

Committee Members
Speaker at International Conference on Clinical & Translational Oncology 2026 - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
ICTO 2026 Speakers
Speaker at International Conference on Clinical & Translational Oncology 2026 - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Speaker at International Conference on Clinical & Translational Oncology 2026 - Sergey Suchkov

Sergey Suchkov

N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Speaker at International Conference on Clinical & Translational Oncology 2026 - Shinya Tajima

Shinya Tajima

National Hospital Organization Shizuoka Medical Centre, Japan
Speaker at International Conference on Clinical & Translational Oncology 2026 - Nayara Delgado Andre

Nayara Delgado Andre

Federal University of São João del-Rei (UFSJ), Brazil

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp